KR20100044239A - 알푸조신 염산염의 제조방법 - Google Patents
알푸조신 염산염의 제조방법 Download PDFInfo
- Publication number
- KR20100044239A KR20100044239A KR1020107004281A KR20107004281A KR20100044239A KR 20100044239 A KR20100044239 A KR 20100044239A KR 1020107004281 A KR1020107004281 A KR 1020107004281A KR 20107004281 A KR20107004281 A KR 20107004281A KR 20100044239 A KR20100044239 A KR 20100044239A
- Authority
- KR
- South Korea
- Prior art keywords
- alfuzosin
- acid
- amino
- process according
- dimethoxyquinazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- JHOGUYCLELTCTL-UHFFFAOYSA-N CCN(CCCN(C)C(N=C(C1C2)N=C)=NC1=CC(OC)=C2OC)C(C1OCCC1)=O Chemical compound CCN(CCCN(C)C(N=C(C1C2)N=C)=NC1=CC(OC)=C2OC)C(C1OCCC1)=O JHOGUYCLELTCTL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1493/MUM/2007 | 2007-08-02 | ||
| IN1493MU2007 | 2007-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20100044239A true KR20100044239A (ko) | 2010-04-29 |
Family
ID=40304963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020107004281A Withdrawn KR20100044239A (ko) | 2007-08-02 | 2008-08-01 | 알푸조신 염산염의 제조방법 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8716476B2 (enExample) |
| EP (1) | EP2178864B1 (enExample) |
| JP (1) | JP2010535185A (enExample) |
| KR (1) | KR20100044239A (enExample) |
| AU (1) | AU2008281567B2 (enExample) |
| CA (1) | CA2695076A1 (enExample) |
| NZ (1) | NZ582950A (enExample) |
| WO (1) | WO2009016387A2 (enExample) |
| ZA (1) | ZA201000802B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2178864B1 (en) | 2007-08-02 | 2014-07-23 | Cipla Limited | Process for the preparation of alfuzosin hydrochloride |
| CN104893626B (zh) | 2010-03-09 | 2017-08-08 | 汉高知识产权控股有限责任公司 | 用于压敏粘合剂的阳离子的可uv交联的丙烯酸聚合物 |
| AR107672A1 (es) * | 2016-02-22 | 2018-05-23 | Hoffmann La Roche | Proceso para la fabricación de derivados de 3-piperazin-1-il-propilamina |
| CN113801069B (zh) * | 2020-06-15 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种盐酸阿夫唑嗪中间体化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2421888A1 (fr) * | 1978-02-06 | 1979-11-02 | Synthelabo | Amides d'alkylene-diamines et leur application en therapeutique |
| YU70890A (en) | 1989-04-21 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for obtaining quinazoline derivatives |
| JPH07206857A (ja) | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
| WO2006090268A2 (en) * | 2005-02-28 | 2006-08-31 | Glenmark Pharmaceuticals Limited | Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin |
| US20070066824A1 (en) | 2005-09-22 | 2007-03-22 | Anumula Raghupathi R | Preparation of alfuzosin |
| US20070105880A1 (en) * | 2005-11-08 | 2007-05-10 | Torrent Pharmaceuticals Limited | Process for the preparation of alfuzosin |
| EP1968970A2 (en) * | 2005-12-16 | 2008-09-17 | Wockhardt Limited | Processes for the preparation of alfuzosin |
| WO2007074364A1 (en) * | 2005-12-26 | 2007-07-05 | Aurobindo Pharma Limited | Process for the preparation of alfuzosin |
| WO2008114272A2 (en) * | 2007-03-22 | 2008-09-25 | Cadila Healthcare Limited | Process for preparing alpuzosin and crystalline alfuzosin hydrochloride |
| EP2178864B1 (en) | 2007-08-02 | 2014-07-23 | Cipla Limited | Process for the preparation of alfuzosin hydrochloride |
-
2008
- 2008-08-01 EP EP08788253.6A patent/EP2178864B1/en not_active Not-in-force
- 2008-08-01 KR KR1020107004281A patent/KR20100044239A/ko not_active Withdrawn
- 2008-08-01 AU AU2008281567A patent/AU2008281567B2/en not_active Ceased
- 2008-08-01 US US12/671,418 patent/US8716476B2/en not_active Expired - Fee Related
- 2008-08-01 WO PCT/GB2008/002632 patent/WO2009016387A2/en not_active Ceased
- 2008-08-01 JP JP2010518741A patent/JP2010535185A/ja active Pending
- 2008-08-01 NZ NZ582950A patent/NZ582950A/en not_active IP Right Cessation
- 2008-08-01 CA CA2695076A patent/CA2695076A1/en not_active Abandoned
-
2010
- 2010-02-03 ZA ZA2010/00802A patent/ZA201000802B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009016387A2 (en) | 2009-02-05 |
| EP2178864A2 (en) | 2010-04-28 |
| JP2010535185A (ja) | 2010-11-18 |
| NZ582950A (en) | 2011-06-30 |
| EP2178864B1 (en) | 2014-07-23 |
| ZA201000802B (en) | 2010-12-29 |
| US8716476B2 (en) | 2014-05-06 |
| AU2008281567A1 (en) | 2009-02-05 |
| US20100256370A1 (en) | 2010-10-07 |
| WO2009016387A3 (en) | 2009-07-02 |
| CA2695076A1 (en) | 2009-02-05 |
| AU2008281567B2 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101541818B (zh) | 4'-叠氮基胞苷衍生物的制备方法 | |
| CN1930127B (zh) | 用于合成cxcr4拮抗剂的方法 | |
| JP2009503120A (ja) | イマチニブの調製方法 | |
| WO2008005423A1 (en) | Improved method of making sufentanil | |
| KR20100044239A (ko) | 알푸조신 염산염의 제조방법 | |
| JP2002505322A (ja) | 保護−４−アミノメチル−ピロリジン−３−オンの製造方法 | |
| JPH08501573A (ja) | 気道のぜん息および炎症の治療に有用な１，４‐ジ置換されたピペラジン | |
| US6469172B2 (en) | Process for the preparation of chemical compounds | |
| WO2018032555A1 (zh) | 二氢异吲哚衍生物及其类似物的制备方法 | |
| JPH11349565A (ja) | ピリドンカルボン酸誘導体の製造方法およびその中間体 | |
| US20130085304A1 (en) | Processes for preparation of polymorphic forms of lacosamide | |
| JP4356111B2 (ja) | Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法 | |
| US20090312351A1 (en) | Processes for the Preparation of Alfuzosin | |
| CN117343006B (zh) | 一种arb-272572的制备方法 | |
| JP2003509504A (ja) | リトナビルの合成方法 | |
| JP4181233B2 (ja) | ピロリジン−２，４−ジオン誘導体の製法 | |
| CN101809022B (zh) | 表鬼臼毒素的抗癌性(多)氨基烷基氨基乙酰胺衍生物的合成方法 | |
| WO2017081701A1 (en) | An improved process for the preparation of thalidomide | |
| AU2017409559B2 (en) | An improved process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin -4-amine dihydrochloride | |
| KR101421032B1 (ko) | (2-메틸-1-(3-메틸벤질)-1Ｈ-벤조[d]이미다졸-5일)(피페리딘-5-일)메탄온의 제조방법 | |
| WO2009001369A1 (en) | An improved process for the preparation of alfuzosin hydrochloride | |
| CN101910148B (zh) | 制备十二氢-萘并-呋喃基-氨基甲酸酯中间体的高纯度合成方法 | |
| JPH0967347A (ja) | 環状アミン誘導体及びそれを含有する医薬組成物 | |
| JP2009510017A (ja) | （３−クロロ−４−フルオロフェニル）−（４−フルオロ−４−｛［（５−メチル−ピリミジン−２−イルメチル）−アミノ］−メチル｝−ピペリジン−１−イル）−メタノンの製造方法および新規な中間体ピリミジン誘導体 | |
| JPH0616624A (ja) | ３−アミノ−４，４−ジアルキルピロリジン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20100226 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |